Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

Metformin is a biguanide oral hypoglycaemic agent commonly used for the treatment of type 2 diabetes mellitus. In addition to its anti-diabetic effect, metformin has also been associated with a reduced risk of...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vIBlEo
via IFTTT